首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques
【24h】

Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques

机译:使用互补质谱技术进行治疗白蛋白化学官能化的动力学和结构特征

获取原文
获取原文并翻译 | 示例
           

摘要

Protein conjugates such as antibody-drugs conjugates (ADCs) represents the next generation of therapeutic proteins. They allow to combine the biological properties of the protein format with the characteristics of the conjugated ligands. The reaction implemented to couple ligands to the peptide backbone represents a crucial aspect of the production of protein conjugates, influencing the nature and the heterogeneity of the conjugates obtained. Here, we report the concomitant use of MALDI-TOF MS and LC-MS/MS analysis to investigate the chemical functionalization of human serum albumin (HSA) by the intermediate of lysine residues, previously used to generate biopharmaceutical agents for medical imaging. A kinetic was performed by collecting samples after different reaction times and analyzing them using the two techniques. MALDI-TOF MS analyses allowed estimating the number of conjugated ligands in a robust manner and assess the global functionalization kinetic on the intact protein level. Results demonstrated a maximum of 38 modified residues out of the 59 lysines available showing the limitation of the chemical functionalization. Consequently, LC-MS/MS analysis provided a site-specific characterization of the residues undergoing chemical modification. Data exhibited unique properties due to the presence of the ligands which allowed to identify without ambiguity the residues exhibiting different modification rate and enabled the identification of the unmodified lysine. Results were compared to the structure of HSA described from crystallography data. The comparison strongly suggested that accessibility is influencing the residues respective reactivity. The relevant complementarity of the different techniques could be emphasized in order to perform an extensive characterization concerning the evolution of the primary structure of the protein during the chemical reaction, providing an improved insight on the conjugation process and offering the potentiality to tune the reaction. (C) 2020 Elsevier B.V. All rights reserved.
机译:蛋白质缀合物如抗体 - 药物缀合物(ADC)代表下一代治疗蛋白。它们允许将蛋白质形式的生物学特性与共轭配体的特性结合。实施的反应将配体耦合到肽骨架表示蛋白质缀合物的产生,影响所获得的缀合物的性质和异质性的关键方面。在这里,我们报告了MALDI-TOF MS和LC-MS / MS / MS分析的伴随使用,以通过赖氨酸残基的中间体来研究人血清白蛋白(HSA)的化学官能化,以便为医学成像产生生物制药代理。通过在不同反应时间后收集样品并使用两种技术分析它们来进行动力学。 MALDI-TOF MS分析允许以稳健的方式估计共轭配体的数量,并评估完整蛋白质水平的全局官能化动力学。结果显示出59个赖氨酸的最多38个改性残基,显示出化学官能化的限制。因此,LC-MS / MS分析提供了经历化学改性的残留物的特异性特异性。由于存在的配体,数据表现出独特的性质,其允许在没有模糊的情况下鉴定具有不同修饰率的残留物并使未修饰的赖氨酸鉴定。将结果与晶体学数据描述的HSA的结构进行比较。比较强烈建议可访问性正在影响残留物的相应反应性。可以强调不同技术的相关互补性,以便在化学反应过程中进行广泛的表征,了解蛋白质主要结构的演变,为缀合过程提供了改进的洞察力,并提供潜力调节反应的潜力。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号